1Peyrin-Biroulet, L, Desreumaux, P, Sandborn, WJ, et al. (2008) Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet 372, 67–81.
2Loftus, EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504–1517.
3Xavier, RJ & Podolsky, DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427–434.
4Peyrin-Biroulet, L, Gueant-Rodriguez, RM, Chen, M, et al. (2008) Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn's disease. Am J Gastroenterol 103, 399–406.
5Peyrin-Biroulet, L, Rodriguez-Gueant, RM, Chamaillard, M, et al. (2007) Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol 102, 1108–1115.
6Chen, M, Xia, B, Rodriguez-Gueant, RM, et al. (2005) Genotypes 677TT and 677CT+1298AC of methylenetetrahydrofolate reductase are associated with the severity of ulcerative colitis in central China. Gut 54, 733–734.
7Mahmud, N, Molloy, A, McPartlin, , et al. (1999) Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45, 389–394.
8Danese, S, Sgambato, A, Papa, A, et al. (2005) Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 100, 886–895.
9Morgenstern, I, Raijmakers, MT, Peters, WH, et al. (2003) Homocysteine, cysteine, and glutathione in human colonic mucosa: elevated levels of homocysteine in patients with inflammatory bowel disease. Dig Dis Sci 48, 2083–2090.
10Chen, M, Peyrin-Biroulet, L, George, A, et al. (2011) Methyl deficient diet aggravates experimental colitis in rats. J Cell Mol Med 15, 2486–2497.
11Bossenmeyer-Pourie, C, Blaise, S, Pourie, G, et al. (2010) Methyl donor deficiency affects fetal programming of gastric ghrelin cell organization and function in the rat. Am J Pathol 176, 270–277.
12Peyrin-Biroulet, L, Loftus, EV, Colombel, JF, et al. (2010) Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. Am J Gastroenterol 105, 289–297.
13Mudter, J & Neurath, MF (2007) Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 56, 293–303.
14Ina, K, Itoh, J, Fukushima, K, et al. (1999) Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 163, 1081–1090.
15Zhang, C, Cai, Y, Adachi, MT, et al. (2001) Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276, 35867–35874.
16Henderson, P, van Limbergen, JE, Schwarze, J, et al. (2011) Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflamm Bowel Dis 17, 382–395.
17Roda, G, Sartini, A, Zambon, E, et al. (2010) Intestinal epithelial cells in inflammatory bowel diseases. World J Gastroenterol 16, 4264–4271.
18Malo, MS, Alam, SN, Mostafa, G, et al. (2010) Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut 59, 1476–1484.
19Wehkamp, J, Koslowski, M, Wang, G, et al. (2008) Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease. Mucosal Immunol 1, Suppl. 1, S67–S74.
20Peyrin-Biroulet, L, Beisner, J, Wang, G, et al. (2010) Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A 107, 8772–8777.
21Clevers, H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127, 469–480.
22Blaise, S, Alberto, JM, Nedelec, E, et al. (2005) Mild neonatal hypoxia exacerbates the effects of vitamin-deficient diet on homocysteine metabolism in rats. Pediatr Res 57, 777–782.
23Selhub, J (1999) Homocysteine metabolism. Annu Rev Nutr 19, 217–246.
24Cox, WG & Singer, VL (1999) A high-resolution, fluorescence-based method for localization of endogenous alkaline phosphatase activity. J Histochem Cytochem 47, 1443–1456.
25Verzola, D, Gandolfo, MT, Ferrario, F, et al. (2007) Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 72, 1262–1272.
26Scott, IS, Morris, LS, Bird, K, et al. (2003) A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer. J Pathol 201, 187–197.
27Giaginis, C, Vgenopoulou, S, Vielh, P, et al. (2010) MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol 25, 351–370.
28Stoeber, K, Tlsty, TD & Happerfield, L (2001) DNA replication licensing and human cell proliferation. J Cell Sci 114, 2027–2041.
29Lalles, JP (2010) Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 68, 323–332.
30Park, CS, Kim, SI, Lee, MS, et al. (2004) Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2. J Biol Chem 279, 19592–19599.
31Battaglia-Hsu, SF, Akchiche, N, Noel, N, et al. (2009) Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE. Proc Natl Acad Sci U S A 106, 21930–21935.
32Janssens, V & Goris, J (2001) Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353, 417–439.
33Lu, X, Freund, JN, Muller, M, et al. (2008) Differential regulation of CDX1 and CDX2 gene expression by deficiency in methyl group donors. Biochimie 90, 697–697.
34Coskun, M, Troelsen, JT & Nielsen, OH (2011) The role of CDX2 in intestinal homeostasis and inflammation. Biochim Biophys Acta 1812, 283–289.
35Heazlewood, CK, Cook, MC, Eri, R, et al. (2008) Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 5, e54.
36Wehkamp, J, Salzman, NH, Porter, E, et al. (2005) Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 102, 18129–18134.
37Blaise, SA, Nédélec, E, Schroeder, H, et al. (2007) Gestational vitamin B deficiency leads to homocysteine-associated brain apoptosis and alters neurobehavioral development in rats. Am J Pathol 170, 667–679.
38Vijayalakshhmi, B, Sesikeran, B, Udaykumar, P, et al. (2005) Effects of vitamin restriction and supplementation on rat intestinal epithelial cell apoptosis. Free Radic Biol Med 38, 1614–1624.
39Mattson, MP & Shea, TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26, 137–146.
40Zou, T, Yang, W, Hou, Z, et al. (2010) Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox. Acta Biochim Biophys Sin (Shanghai) 42, 908–915.
41Zou, CG, Zhao, YS, Gao, SY, et al. (2010) Homocysteine promotes proliferation and activation of microglia. Neurobiol Aging 31, 2069–2079.
42Zhang, Q, Zeng, X, Guo, J, et al. (2001) Effects of homocysteine on murine splenic B lymphocyte proliferation and its signal transduction mechanism. Cardiovasc Res 52, 328–336.
43Liu, WH, Zhao, YS, Gao, SY, et al. (2010) Hepatocyte proliferation during liver regeneration is impaired in mice with methionine diet-induced hyperhomocysteinemia. Am J Pathol 177, 2357–2365.
44Zhang, HS, Cao, EH & Qin, JF (2005) Homocysteine induces cell cycle G1 arrest in endothelial cells through the PI3K/Akt/FOXO signaling pathway. Pharmacology 74, 57–64.
45Maiorano, D, Cuvier, O, Danis, E, et al. (2005) MCM8 is an MCM2-7-related protein that functions as a DNA helicase during replication elongation and not initiation. Cell 120, 315–328.
46McGuckin, MA, Eri, R, Simms, LA, et al. (2009) Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 15, 100–113.
47Tuin, A, Poelstra, K, de Jager-Krikken, A, et al. (2009) Role of alkaline phosphatase in colitis in man and rats. Gut 58, 379–387.
48Hendrickson, BA, Gokhale, R & Cho, JH (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15, 79–94.
49Takahashi-Yanaga, F & Sasaguri, T (2007) The Wnt/beta-catenin signalling pathway as a target in drug discovery. J Pharmacol Sci 104, 293–302.
50Yang, Q, Bermingham, NA, Finegold, MJ, et al. (2001) Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294, 2155–2158.
51Shroyer, NF, Wallis, D, Venken, KJ, et al. (2005) Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation. Genes Dev 19, 2412–2417.
52Van der Sluis, M, De Koning, BA, De Bruijn, AC, et al. (2006) Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131, 117–129.
53Smithson, JE, Campbell, A, Andrews, JM, et al. (1997) Altered expression of mucins throughout the colon in ulcerative colitis. Gut 40, 234–240.
54Van Klinken, BJ, Van der Wal, JW, Einerhand, AW, et al. (1999) Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 44, 387–393.
55Heller, F, Florian, P, Bojarski, C, et al. (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550–564.
56Karlsson, J, Putsep, K, Chu, H, et al. (2008) Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract. BMC Immunol 9, 37.
57Said, H (2011) Intestinal absorption of water-soluble vitamins in health and disease. Biochem J 437, 357–372.
58Quadros, E (2010) Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol 148, 195–204.